scholarly journals Combined Descemet stripping automated endothelial keratoplasty and intravitreal dexamethasone implant for concomitant pseudophakic bullous keratopathy and cystoid macular edema

2019 ◽  
Vol 12 (5) ◽  
2015 ◽  
Vol 25 (5) ◽  
pp. e98-e100 ◽  
Author(s):  
Vincenza Bonfiglio ◽  
Matteo R. Fallico ◽  
Andrea Russo ◽  
Vittorio De Grande ◽  
Antonio Longo ◽  
...  

Retina ◽  
2020 ◽  
Vol 40 (7) ◽  
pp. 1359-1366
Author(s):  
Un Chul Park ◽  
Jung Hyun Park ◽  
Dae Joong Ma ◽  
In Hwan Cho ◽  
Baek-Lok Oh ◽  
...  

2018 ◽  
Vol 9 (1) ◽  
pp. 149-154
Author(s):  
Andleeb Zafar ◽  
Ioannis M. Aslanides ◽  
Vasileios Selimis ◽  
Konstantinos I. Tsoulnaras ◽  
David Tabibian ◽  
...  

Purpose: We report here the case of a patient with anterior segment migration of intravitreal dexamethasone implant as well as its management and outcome. Methods: The patient had the following sequence of events: complicated cataract surgery, iris-sutured intraocular lens implant, followed by cystoid macular edema treated with intravitreal Avastin, retinal vein occlusion treated with intravitreal dexamethasone implant, corneal decompensation treated with Descemet stripping automated endothelial keratoplasty (DSAEK), and finally recurrence of macular edema treated with repeated intravitreal dexamethasone implant. Results: Dexamethasone implant had completely dissolved from the eye 12 weeks after insertion without any complication. Conclusion: A conservative approach with regular monitoring in the situation of a quiet anterior segment without any corneal decompensation can provide enough time for the implant to dissolve without causing any complication to the involved eye, avoiding any additional surgical intervention, as presented in this case report. Despite the fact that the implant was left for natural dissolution, there were no adverse effects related to the graft or the eye.


2018 ◽  
Vol 2018 ◽  
pp. 1-3 ◽  
Author(s):  
Cassandra C. Lautredou ◽  
Joshua S. Hardin ◽  
John R. Chancellor ◽  
Sami H. Uwaydat ◽  
Abdallah A. Ellabban ◽  
...  

Purpose. To report the successful utilization of adjunctive repeat intravitreal corticosteroid therapy for the treatment of cystoid macular edema in syphilis-related uveitis. Methods/Patients. An HIV-positive patient with treated ocular syphilis who developed refractory cystoid macular edema (CME) was treated with repeat intravitreal corticosteroid therapy including dexamethasone intravitreal implants. Results. Treatment led to the resolution of CME and improvement in visual acuity. Conclusions. Intravitreal corticosteroid therapy may be a viable adjunctive treatment for refractory CME in patients with treated syphilitic uveitis. Corticosteroid-induced exacerbation of infection is unlikely in patients with an adequate serologic treatment response.


Sign in / Sign up

Export Citation Format

Share Document